Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 27, 2012

View Archived Issues

TMX-202 shows potential as intravesically administered bladder cancer therapy

Orteronel investigated in nonmetastatic prostate cancer

Updated results presented from the AXIS trial

New VCP inhibitors designed in Japan

Novel metabotropic glutamate mGlu2 receptor antagonists patented

Prous Institute for Biomedical Research reports new multitargeted products

Eli Lilly presents novel products with potential to treat cancer

New 11-beta-HSD1 inhibitors developed at High Point Pharmaceuticals

Auriga identifies novel potential therapeutics for photodermatosis

Selective serotonin transporter radioligand investigated in healthy subjects and patients

Sirona Biochem assesses lead product in model of diabetes

Novartis seeks Afinitor line extensions in Japan

EMA accepts Takeda's MAA for peginesatide

Angiochem and GSK launch new collaboration

Eisai offers overview of third quarter of fiscal 2011

Neuronex enters merger agreement

CSL Behring screens first patient in global rVIII-SingleChain study

European Commission approves Glivec label update

Chinese institute divulges new beta-secretase 1 inhibitors

Esmya approved in Europe

Scripps Research Institute receives funds to develop new HIV inhibitors

Sanofi discloses new platelet adhesion-inhibiting peptides

Galen acquires chemotherapy agent from Gilead

FDA approves protocol amendment to ARISER study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...